These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24314416)

  • 1. No ocular motility complications after subtenon topotecan with fibrin sealant for retinoblastoma.
    Yousef YA; Halliday W; Chan HS; Héon E; Gallie BL; Dimaras H
    Can J Ophthalmol; 2013 Dec; 48(6):524-8. PubMed ID: 24314416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
    Mulvihill A; Budning A; Jay V; Vandenhoven C; Heon E; Gallie BL; Chan HS
    Arch Ophthalmol; 2003 Aug; 121(8):1120-4. PubMed ID: 12912689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity to sub-Tenon's topotecan in fibrin adhesive in patients with retinoblastoma.
    Astudillo PP; Durairaj P; Chan HS; Héon E; Gallie BL
    J AAPOS; 2015 Feb; 19(1):86-7. PubMed ID: 25727598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periocular topotecan for intraocular retinoblastoma.
    Mallipatna AC; Dimaras H; Chan HS; Héon E; Gallie BL
    Arch Ophthalmol; 2011 Jun; 129(6):738-45. PubMed ID: 21670340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
    Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
    Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience.
    Francis JH; Brodie SE; Marr B; Zabor EC; Mondesire-Crump I; Abramson DH
    Ophthalmology; 2017 Apr; 124(4):488-495. PubMed ID: 28089679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
    Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
    JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results.
    Marr BP; Brodie SE; Dunkel IJ; Gobin YP; Abramson DH
    Br J Ophthalmol; 2012 Oct; 96(10):1300-3. PubMed ID: 22863945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma.
    Abramson DH; Fabius AW; Francis JH; Marr BP; Dunkel IJ; Brodie SE; Escuder A; Gobin YP
    Ophthalmic Genet; 2017; 38(1):16-21. PubMed ID: 28095092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
    Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
    J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
    Ophthalmology; 2024 Oct; 131(10):1215-1224. PubMed ID: 38703794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.
    Kiratli H; Koç I; Öztürk E; Varan A; Akyüz C
    Jpn J Ophthalmol; 2020 Jul; 64(4):351-358. PubMed ID: 32447585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity.
    Marr BP; Dunkel IJ; Linker A; Abramson DH
    Br J Ophthalmol; 2012 Jun; 96(6):881-3. PubMed ID: 22328819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.